Stay updated on Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added Thymus cancer to the related conditions and included a Genetic and Rare Diseases Information Center resources link.
    Difference
    0.2%
    Check dated 2026-03-18T14:52:35.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T17:14:11.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; the notice about lapse in government funding and the Revision: v3.4.1 entry were removed.
    Difference
    0.4%
    Check dated 2026-02-11T05:43:32.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and potential data delays was added. The site revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T05:21:22.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Added a glossary display, introduced a new 'Last Update Submitted that Met QC Criteria' label, and updated the capitalization to 'No FEAR Act Data'. Updated the revision reference from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T03:24:18.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    Revision: v3.3.4 update shows no substantive changes to the study details, eligibility criteria, locations, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:29:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page.